| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/02/2007 | EP1780221A1 Anti-synoviolin antibody |
| 05/02/2007 | EP1780220A1 Use of CEACAM8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779865A1 Use of human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 05/02/2007 | EP1779864A1 Pth-containing preparation for transmucosal administration |
| 05/02/2007 | EP1779848A1 V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases |
| 05/02/2007 | EP1778727A1 Antibody specific for a chondroitin sulphate epitope |
| 05/02/2007 | EP1778693A2 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 05/02/2007 | EP1778360A2 Compositions and methods for viscosupplementation |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1778240A2 Dihydropteridinones for the treatment of cancer diseases |
| 05/02/2007 | EP1576160B1 Borrelidin-derivatives and their use in medicine |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | EP1121115B1 Pufa supplements |
| 05/02/2007 | EP0869968B1 Growth-hormone secretagogues |
| 05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
| 05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955163A Cyclooxygenase-2 selection inhibitor and its medicine use |
| 05/02/2007 | CN1954877A Chinese medicinal composite for treating ischemic necrosis of femoral head and its preparation method |
| 05/02/2007 | CN1954834A Traditional Chinese medicine gels for treating acute gout arthritis |
| 05/02/2007 | CN1954814A Medical composite with co-action for treating gout and its preparation method |
| 05/02/2007 | CN1954801A Apple vinegar skin toning cream |
| 05/02/2007 | CN1954799A Deacne pack |
| 05/02/2007 | CN1313463C Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313159C Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313143C External-use traditional Chinese medicine for treating arthropathy hyperosteogeny |
| 05/02/2007 | CN1313131C Traditional Chinese medicine for treating neck disease |
| 05/02/2007 | CN1313129C Traditional Chinese medicine composition for preparing drug for treating hyperosteogeny and disc protrusion |
| 05/02/2007 | CN1313124C Health medicinal wine for traumatic injury |
| 05/02/2007 | CN1313123C External used Chinese medicinal preparation for bone fracture and its preparing method |
| 05/02/2007 | CN1313117C Chinese medicine external applied powder for bone damage |
| 05/02/2007 | CN1313111C Chinese medicinal extract for resisting osteoporosis and its preparation |
| 05/02/2007 | CN1313110C Oteoproliferation treating plaster |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211666 N-Cyclopropyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide; aminating with chloramine to produce a pyrrole with a Nitrogen nitrogen bond; reacting with formamide, cyclizing to form the pyrrolotriazine core; kinase inhibitors |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211604 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents |
| 05/01/2007 | US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211399 Method for detecting leptin receptor ligands |
| 05/01/2007 | US7211387 DNA molecule encoding a variant paraoxonase and uses thereof |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2308922C Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 05/01/2007 | CA2227205C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2120303C Cyclic adhesion inhibitors |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007046123A2 Composition containing vitamins k and d as well as taurine for the preventio and treatment of osteoporosis |
| 04/26/2007 | WO2007045927A2 Therapeutic agent |
| 04/26/2007 | WO2007020527A3 Process for the preparation of strontium ranelate |
| 04/26/2007 | WO2007014839A3 Cathepsin k inhibitors |
| 04/26/2007 | WO2006099233A3 Compositions and methods for the treatment of osteoporosis and inflammatory joint disease |
| 04/26/2007 | WO2006042724A3 Magnetic particles for therapy and diagnosis |
| 04/26/2007 | US20070093553 HMB compositions and uses thereof |
| 04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
| 04/26/2007 | US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases |
| 04/26/2007 | US20070093482 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/25/2007 | EP1777235A1 Compositions and methods for treating inflammatory disorders |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776956A1 Preventive and/or therapeutic agent for calcipenia |
| 04/25/2007 | EP1776366A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 04/25/2007 | EP1776138A1 tRNA SYNTHETASE FRAGMENTS |
| 04/25/2007 | EP1776123A1 Risedronate compositions and their methods of use |
| 04/25/2007 | EP1776106A1 Heterocyclic derivatives for modulation of calcium channels |
| 04/25/2007 | EP1537100B1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953756A Insulin resistance improving agent |